1st Session: 20 Years of Cancer Policy Advocacy

  • Tackling Cancer: An EU Priority – Stella Kyriakides

  • Making cancer research accessible to cancer patients – Mary Bussell

  • Celebrating the 20 years of ECPC – Addresses of ECPC stakeholders – Alberto Costa

  • Celebrating the 20 years of ECPC – Addresses of ECPC stakeholders – Jens Habermann

  • Celebrating the 20 years of ECPC – Addresses of ECPC stakeholders – Manuela Pausan

  • Celebrating the 20 years of ECPC – Addresses of ECPC stakeholders – Elisabetta Iannelli

  • Welcome Address – Francesco de Lorenzo


2nd Session: EU Beating Cancer Plan and the Mission on Cancer: How far have we come?

  • The European Commission commitment to beat cancer – Sandra Gallina

  • Making cancer research accessible to cancer patients – Mary Bussell

  • Celebrating the 20 years of ECPC – Addresses of ECPC stakeholders – Alberto Costa

  • Celebrating the 20 years of ECPC – Addresses of ECPC stakeholders – Jens Habermann

  • Celebrating the 20 years of ECPC – Addresses of ECPC stakeholders – Manuela Pausan


3rd Session: The EU Health Policy Landscape

  • What will Change with the New EU Pharmaceutical Strategy? – Elena Petelos

  • How can Patients Claim their Role in the New Health Technology Assessment Regulation? – Dimitra Lingri

  • Access & Diagnostics for All & Public Health Genomics – Denis Horgan

  • Representing the ECPC Patient Perspective in EU Cancer Policies – Adela Maghear


4th Session: The New Cancer Care Delivery Landscape

  • The Comprehensive Cancer Center in the EU Cancer Plan: How can EU health systems adapt to the proposed model – Anton Berns

  • Importance of Networks of Expertise: the EU Joint Action – JANE – Paolo Casali

  • Patient Involvement in the New Cancer Care Delivery Landscape – Francesco de Lorenzo


5th Session: The Inequalities in Cancer Care

  • Socio-economic disparities in cancer in Romania: Are they addressed in the new Romanian National Cancer Control Plan? – Delia Nicoara

  • The ECPC White Paper on Socio-economic Disparities in Cancer in Europe – Francesco de Lorenzo, Roberto de Miro

  • PJob Retention and Return to Work for Cancer Patients and Survivors – Regine Kiasuwa

  • The Right to Be Forgotten: A Cancer Patient’s Right that Becomes a Law – Francoise Meunier


6th Session: Role of Biomarkers in Personalized Medicine

  • Cancer Biomarkers and their Relevance for Patients – Nicola Normanno

  • Introducing the TIGER project – Ritchie Head

  • Innovative imaging biomarkers for HPV + cancers – Wim Vos

  • How Can Cancer Patients advocate for newer biomarker testing? – Kathi Apostolidis